Roadmap To Market For Cell And Gene Therapies

Development of cell and gene therapies is complicated, with every product presenting a unique set of challenges. It’s critical to have an experienced partner to help you engage with regulators and design the study early on. Having executed trials for the first gene therapy approved in Europe, Veristat set the standard for other therapies in development and remains a leader in this specialized area today. With our global team of scientific experts offering strategic insights and custom-tailored solutions, Veristat provides comprehensive end-to-end services, from pre-IND to submissions and approvals.